Skip to content

Clinical trials

Phase 2 Inflammation trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammation Phase: Phase 2 Country / region: United Kingdom Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20082
20112
20121
20132
20151
20161
20193
20203
20211
20221
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated5
Recruiting3
Unknown status2
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Novo Nordisk A/S3
Novartis Pharmaceuticals2
University of Edinburgh2
Abcentra1
Aerovance, Inc.1
Amgen1
CCTU-Core1
Cambridge University Hospitals NHS Foundation Trust1
Centocor, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammation23
Arthritis, Rheumatoid3
Asthma3
Pulmonary Disease, Chronic Obstructive3
Alzheimer Disease2
Cognitive Dysfunction2
Crohn Disease2
Dementia2
Myocardial Infarction2
Acute Coronary Syndrome1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.